Page 1 | Search Results | Diabetes | American Diabetes Association

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes: Results From the Finnish Diabetes Prevention Study

Christian Herder, Markku Peltonen, Wolfgang Koenig, Ilka Kräft, Sylvia Müller-Scholze, Stephan Martin, Timo Lakka, Pirjo Ilanne-Parikka, Johan G. Eriksson, Helena Hämäläinen, Sirkka Keinänen-Kiukaanniemi, Timo T. Valle, Matti Uusitupa, Jaana Lindström, Hubert Kolb, Jaakko Tuomilehto, for the Finnish Diabetes Prevention Study Group

Diabetes 2006;55(8):2340–2346

https://doi.org/10.2337/db05-1320

Published: 01 August 2006

View articletitled, Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes: Results From the Finnish Diabetes Prevention Study

Journal Articles

Association of Systemic Chemokine Concentrations With Impaired Glucose Tolerance and Type 2 Diabetes: Results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)

Christian Herder, Burkhard Haastert, Sylvia Müller-Scholze, Wolfgang Koenig, Barbara Thorand, Rolf Holle, H.-Erich Wichmann, Werner A. Scherbaum, Stephan Martin, Hubert Kolb

Diabetes 2005;54(suppl_2):S11–S17

https://doi.org/10.2337/diabetes.54.suppl_2.S11

Published: 01 December 2005

View articletitled, Association of Systemic Chemokine Concentrations With Impaired Glucose Tolerance and Type 2 Diabetes: Results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)

Journal Articles

Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes: Results From the MONICA/KORA Augsburg Study, 1984–2002

Barbara Thorand, Hubert Kolb, Jens Baumert, Wolfgang Koenig, Lloyd Chambless, Christa Meisinger, Thomas Illig, Stephan Martin, Christian Herder

Diabetes 2005;54(10):2932–2938

https://doi.org/10.2337/diabetes.54.10.2932

Published: 01 October 2005

View articletitled, Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes: Results From the MONICA/KORA Augsburg Study, 1984–2002

Journal Articles

C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function : Report of an ADA Workshop, 21–22 October 2001

Jerry P. Palmer, G. Alexander Fleming, Carla J. Greenbaum, Kevan C. Herold, Lisa D. Jansa, Hubert Kolb, John M. Lachin, Kenneth S. Polonsky, Paolo Pozzilli, Jay S. Skyler, Michael W. Steffes

Diabetes 2004;53(1):250–264

https://doi.org/10.2337/diabetes.53.1.250

Published: 01 January 2004

View articletitled, C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function : Report of an ADA Workshop, 21–22 October 2001

Journal Articles

The Endotoxin Receptor TLR4 Polymorphism Is Not Associated With Diabetes or Components of the Metabolic Syndrome

Thomas Illig, Friedhelm Bongardt, Andreas Schöpfer, Rolf Holle, Sylvia Müller, Wolfgang Rathmann, Wolfgang Koenig, Christa Meisinger, H.-Erich Wichmann, Hubert Kolb, For The KORA Study Group

Diabetes 2003;52(11):2861–2864

https://doi.org/10.2337/diabetes.52.11.2861

Published: 01 November 2003

View articletitled, The Endotoxin Receptor TLR4 Polymorphism Is Not Associated With Diabetes or Components of the Metabolic Syndrome

Journal Articles

An Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes

Pejman Hanifi-Moghaddam, Nanette C. Schloot, Simone Kappler, Jochen Seiβler, Hubert Kolb

Diabetes 2003;52(5):1137–1142

https://doi.org/10.2337/diabetes.52.5.1137

Published: 01 May 2003

View articletitled, An Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes

Journal Articles

Oral Exposure to Diabetes-Promoting Food or Immunomodulators in Neonates Alters Gut Cytokines and Diabetes

Fraser W. Scott, Paul Rowsell, Gen-Sheng Wang, Karolina Burghardt, Hubert Kolb, Stefanie Flohé

Diabetes 2002;51(1):73–78

https://doi.org/10.2337/diabetes.51.1.73

Published: 01 January 2002

View articletitled, Oral Exposure to Diabetes-Promoting Food or Immunomodulators in Neonates Alters Gut Cytokines and Diabetes

Journal Articles

Potential Mechanisms by Which Certain Foods Promote or Inhibit the Development of Spontaneous Diabetes in BB Rats: Dose, Timing, Early Effect on Islet Area, and Switch in Infiltrate From Th1 to Th2 Cells

Fraser W Scott, Heather E Cloutier, Rainer Kleemann, Ute Wöerz-Pagenstert, Paul Rowsell, H Wayne Modler, Hubert Kolb

Diabetes 1997;46(4):589–598

https://doi.org/10.2337/diab.46.4.589

Published: 01 April 1997

View articletitled, Potential Mechanisms by Which Certain Foods Promote or Inhibit the Development of Spontaneous Diabetes in BB Rats: Dose, Timing, Early Effect on Islet Area, and Switch in Infiltrate From Th1 to Th2 Cells

Journal Articles

Systemic Bias of Cytokine Production Toward Cell-Mediated Immune Regulation in IDDM and Toward Humoral Immunity in Graves' Disease

Boris A Kallmann, Manfred Hüther, Monika Tubes, Joachim Feldkamp, Jörg Bertrams, Friedrich A Gries, Eberhard F Lampeter, Hubert Kolb

Diabetes 1997;46(2):237–243

https://doi.org/10.2337/diab.46.2.237

Published: 01 February 1997

View articletitled, Systemic Bias of Cytokine Production Toward Cell-Mediated Immune Regulation in IDDM and Toward Humoral Immunity in Graves' Disease

Journal Articles

Low Stress Response Enhances Vulnerability of Islet Cells in Diabetes-Prone BB Rats

Kerstin Bellmann, Liu Hui, Jürgen Radons, Volker Burkart, Hubert Kolb

Diabetes 1997;46(2):232–236

https://doi.org/10.2337/diab.46.2.232

Published: 01 February 1997

View articletitled, Low Stress Response Enhances Vulnerability of Islet Cells in Diabetes-Prone BB Rats

Journal Articles

Islet Cell DNA Is a Target of Inflammatory Attack by Nitric Oxide

Karin Fehsel, Andreas Jalowy, Sun Qi, Volker Burkart, Bettina Hartmann, Hubert Kolb

Diabetes 1993;42(3):496–500

https://doi.org/10.2337/diab.42.3.496

Published: 01 March 1993

View articletitled, Islet Cell DNA Is a Target of Inflammatory Attack by Nitric Oxide

Journal Articles

Elevated Levels of Circulating Adhesion Molecules in IDDM Patients and in Subjects at Risk for IDDM

Eberhard R Lampeter, Takashi K Kishimoto, Robert Rothlein, Elizabeth A Mainolfi, Jorg Bertrams, Hubert Kolb, Stephan Martin

Diabetes 1992;41(12):1668–1671

https://doi.org/10.2337/diab.41.12.1668

Published: 01 December 1992

View articletitled, Elevated Levels of Circulating Adhesion Molecules in IDDM Patients and in Subjects at Risk for IDDM

Journal Articles

Evidence of IgG Autoantibodies Against Human Proinsulin in Patients With IDDM Before Insulin Treatment

Bernd Kuglin, F Arnold Gries, Hubert Kolb

Diabetes 1988;37(1):130–132

https://doi.org/10.2337/diab.37.1.130

Published: 01 January 1988

View articletitled, Evidence of IgG Autoantibodies Against Human Proinsulin in Patients With IDDM Before Insulin Treatment

Journal Articles

Low-Dose Streptozocin-Induced Diabetes in Mice: Electron Microscopy Reveals Single-Cell Insulitis Before Diabetes Onset

Victoria Kolb-Bachofen, Stefan Epstein, Ulrich Kiesel, Hubert Kolb

Diabetes 1988;37(1):21–27

https://doi.org/10.2337/diab.37.1.21

Published: 01 January 1988

View articletitled, Low-Dose Streptozocin-Induced Diabetes in Mice: Electron Microscopy Reveals Single-Cell Insulitis Before Diabetes Onset

Journal Articles

Suppressive Effect of Antibodies to Immune Response Gene Products on the Development of Low-Dose Streptozotocin-induced Diabetes

Ulrich Kiesel, Hubert Kolb

Diabetes 1983;32(9):869–871

https://doi.org/10.2337/diab.32.9.869

Published: 01 September 1983

View articletitled, Suppressive Effect of Antibodies to Immune Response Gene Products on the Development of Low-Dose Streptozotocin-induced Diabetes

Update search

NARROW

Format

Journal

Article Type

Topics

Issue Section

Date

Availability

Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes: Results From the Finnish Diabetes Prevention Study

Association of Systemic Chemokine Concentrations With Impaired Glucose Tolerance and Type 2 Diabetes: Results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)

Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes: Results From the MONICA/KORA Augsburg Study, 1984–2002

C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function : Report of an ADA Workshop, 21–22 October 2001

The Endotoxin Receptor TLR4 Polymorphism Is Not Associated With Diabetes or Components of the Metabolic Syndrome

An Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes

Oral Exposure to Diabetes-Promoting Food or Immunomodulators in Neonates Alters Gut Cytokines and Diabetes

Potential Mechanisms by Which Certain Foods Promote or Inhibit the Development of Spontaneous Diabetes in BB Rats: Dose, Timing, Early Effect on Islet Area, and Switch in Infiltrate From Th1 to Th2 Cells

Systemic Bias of Cytokine Production Toward Cell-Mediated Immune Regulation in IDDM and Toward Humoral Immunity in Graves' Disease

Low Stress Response Enhances Vulnerability of Islet Cells in Diabetes-Prone BB Rats

Islet Cell DNA Is a Target of Inflammatory Attack by Nitric Oxide

Elevated Levels of Circulating Adhesion Molecules in IDDM Patients and in Subjects at Risk for IDDM

Evidence of IgG Autoantibodies Against Human Proinsulin in Patients With IDDM Before Insulin Treatment

Low-Dose Streptozocin-Induced Diabetes in Mice: Electron Microscopy Reveals Single-Cell Insulitis Before Diabetes Onset

Suppressive Effect of Antibodies to Immune Response Gene Products on the Development of Low-Dose Streptozotocin-induced Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Update search

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only